Michael Anstey is a Partner at Cambridge Innovation Capital, where they have been since 2017. Previously, they served as a Principal at The Boston Consulting Group from 2010 to 2017 and co-founded Proteorex Therapeutics Inc. from 2014 to 2018. Michael has held various board roles at companies such as Bicycle Therapeutics, Epitopea, Sense Biodetection Ltd, and Congenica. They earned a DPhil from the University of Oxford and completed the Kauffman Fellowship in 2019.
Location
Cambridge, United Kingdom
This person is not in the org chart
This person is not in any teams
This person is not in any offices